Three or four questions, asked in this order, will tell you within ten minutes whether a Nashville provider is operating under federal compounding law or is something you should walk away from. Ask them exactly as clinicians in similar high-growth doctor-authority markets do, without modification.
1. Can the practitioner explain, in plain terms, why a peptide is being compounded under section 503A — and which pharmacy they work with?
A credible clinician will be able to articulate the regulatory rationale without reaching for marketing copy: section 503A of the FDCA permits a licensed pharmacist to prepare a compound based on a patient-specific prescription when no commercially available equivalent meets the need. They should name the 503A pharmacy and be willing to discuss its inspection history. If a clinic deflects the question, the question itself is the answer.
2. Will baseline labs — IGF-1, hormone panels, metabolic markers — be ordered before any peptide protocol begins?
Ask which baseline tests are appropriate for the specific treatment being considered and who reviews the results. A clinic should explain how its evaluation and monitoring plan relates to your medical history instead of treating every patient as if the same protocol fits.
3. What is the follow-up cadence — at three months, at six months — and who reviews the labs?
Anti-aging protocols are not one-and-done prescriptions. The physician (or a credentialed nurse practitioner with the physician overseeing) should be reviewing repeat labs at fixed intervals and adjusting dose, frequency, or cessation based on what the numbers show. Ask who reviews the labs and how that review is documented.
4. What conditions would cause the physician to stop the protocol — and how is that decision made?
A practitioner who cannot describe their stop-criteria has not thought about them. Reasonable answers include: out-of-range IGF-1, adverse event, lack of symptomatic improvement at a defined checkpoint, or any new contraindication identified during follow-up. If the answer is some version of "we just keep going," that is a position the patient — not the clinic — will eventually have to defend.